India’s Pharma Industry: Poised for Global Expansion by 2030

India’s pharmaceutical industry is on the verge of major expansion, with its share in the global market predicted to climb to 5% by 2030, according to a new report from…

An Index To Gauge States For Drug Enforcement, Improve Drug Quality

New Delhi:  The Union government is drawing up an index to gauge states and union territories on their preparedness to enforce Central regulations on drugs, medical devices and cosmetics, according…

DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets

Mumbai:  The Directorate General of Foreign Trade (DGFT), under the ministry of commerce & industry, has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin…

CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

THIRUVANANTHAPURAM: CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram has developed a technology that converts pathogenic biomedical waste into value-added soil additives that eliminate the need for costly…

As Always Ahead of Game in healthcare, Doc was first to vote too

New Delhi: Dr Aashish Chaudhry, renowned knee replacement surgeon and MD of Aakash Healthcare, is a duty bound healer. He never shirks his duty both as a doctor and a…

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

A leading pharmaceutical powerhouse renowned for innovative skincare solutions has unveiled its latest breakthrough in tackling facial hyperpigmentation. The groundbreaking serum, featuring a first-of-its-kind dual liposomal technology in India, promises…

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners (RMPs) and representatives of pharmaceutical…

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

New Delhi:  Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a…

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Sun Pharmaceutical Industries has appointed Aalok Shanghvi as its Chief Operating Officer (COO). The company announced the designation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.…

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds

Alembic Pharma on Monday reported a 23.29 per cent year-on-year (Y-o-Y) decline in its consolidated profit after tax (PAT) for the third quarter of financial year 2024-25 (Q3FY25) at Rs…